JP2004517947A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517947A5
JP2004517947A5 JP2002562330A JP2002562330A JP2004517947A5 JP 2004517947 A5 JP2004517947 A5 JP 2004517947A5 JP 2002562330 A JP2002562330 A JP 2002562330A JP 2002562330 A JP2002562330 A JP 2002562330A JP 2004517947 A5 JP2004517947 A5 JP 2004517947A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
alkoxy
hydroxy
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002562330A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517947A (ja
Filing date
Publication date
Priority claimed from GBGB0103045.1A external-priority patent/GB0103045D0/en
Application filed filed Critical
Publication of JP2004517947A publication Critical patent/JP2004517947A/ja
Publication of JP2004517947A5 publication Critical patent/JP2004517947A5/ja
Withdrawn legal-status Critical Current

Links

JP2002562330A 2001-02-07 2002-02-06 そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用 Withdrawn JP2004517947A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103045.1A GB0103045D0 (en) 2001-02-07 2001-02-07 Organic Compounds
PCT/EP2002/001250 WO2002062323A2 (en) 2001-02-07 2002-02-06 Use of mglur5 antagonists for the treatment of pruritic conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012084772A Division JP2012131829A (ja) 2001-02-07 2012-04-03 そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用

Publications (2)

Publication Number Publication Date
JP2004517947A JP2004517947A (ja) 2004-06-17
JP2004517947A5 true JP2004517947A5 (https=) 2005-12-22

Family

ID=9908300

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002562330A Withdrawn JP2004517947A (ja) 2001-02-07 2002-02-06 そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用
JP2012084772A Pending JP2012131829A (ja) 2001-02-07 2012-04-03 そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012084772A Pending JP2012131829A (ja) 2001-02-07 2012-04-03 そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用

Country Status (13)

Country Link
US (2) US20040106582A1 (https=)
EP (1) EP1359905B1 (https=)
JP (2) JP2004517947A (https=)
CN (1) CN1253151C (https=)
AT (1) ATE333869T1 (https=)
AU (1) AU2002231777A1 (https=)
BR (1) BR0206917A (https=)
CA (1) CA2433409C (https=)
DE (1) DE60213365T2 (https=)
ES (1) ES2271229T3 (https=)
GB (1) GB0103045D0 (https=)
PT (1) PT1359905E (https=)
WO (1) WO2002062323A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0322612D0 (en) * 2003-09-26 2003-10-29 Novartis Ag Organic compounds
CA2549965A1 (en) * 2003-10-31 2005-05-19 Astrazeneca Ab Alkynes iii
CA2549967A1 (en) * 2003-10-31 2005-05-19 Astrazeneca Ab Alkynes i
EP1677790A1 (en) * 2003-10-31 2006-07-12 AstraZeneca AB Alkynes ii
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508319D0 (en) 2005-04-25 2005-06-01 Novartis Ag Organic compounds
MX2015002555A (es) 2012-08-30 2015-06-23 Nippon Shinyaku Co Ltd Derivado de piridina y medicina.
LT3303316T (lt) 2015-06-03 2020-05-11 F. Hoffmann-La Roche Ag Etinilo dariniai

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013744B1 (en) * 1989-12-29 1994-09-20 Allegran Inc Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity
FR2719044B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
US5534641A (en) * 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5498795A (en) * 1994-12-29 1996-03-12 Allergan, Inc. Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6774138B2 (en) * 1999-08-31 2004-08-10 Merck & Co., Inc. Thiazolyl(pyridyl)ethyne compounds

Similar Documents

Publication Publication Date Title
RU2370495C2 (ru) Дополнительные гетероциклические соединения и их применение в качестве антагонистов метаботропного глутаматного рецептора
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
JP2005536475A5 (https=)
JP2004528312A5 (https=)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
JP2004517087A5 (https=)
JP2009531376A5 (https=)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
GEP201706611B (en) Amido compounds and their use as pharmaceuticals
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2014037426A5 (https=)
GEP20084527B (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
RU2003104794A (ru) Производные 4-фенилпиридина в качестве антагонистов рецептора нейрокинина 1
JP2006515604A5 (https=)
RU2006131304A (ru) Производные имидазо[1,2-c]пиримидинилуксусной кислоты
JP2004517947A5 (https=)
CA2416874A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
WO2010000030A1 (en) Thiazopyrimidinones and uses thereof
ATE359791T1 (de) Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer
WO2007125398A3 (en) : sulfonamide compounds as antagonists of the n-type calcium channel
HRP20110436T1 (hr) Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i
JP2007515467A5 (https=)
CA2433409A1 (en) Use of mglur5 antagonists for the treatment of pruritic conditions
JP2009539874A5 (https=)
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom